Popular anti-nausea medicine linked to drug injuries

On Behalf of | Jun 30, 2016 | Pharmaceutical Litigation

Prescription medication has the power to change a person’s life for the better. With the right medication, a patient can experience less pain and injury and can even have a more fulfilling life. Most physicians in Ohio prescribe medications to patients who they believe can benefit from its use, but few are aware of the serious risks and drug injuries associated with certain prescription drugs.

Pregnant women are an especially vulnerable group of people, and obstetricians usually closely monitor their patients’ uses of medication.  Zofran became a popular drug prescribed to pregnant women after it first received FDA approval in 1991. Typically used to address morning sickness, Zofran had hit the top 20 list of medications most prescribed in the United States.

Unfortunately, this commonly prescribed medication can actually pose a serious risk to unborn children. Zofran is understood to put pregnant women at a higher risk of giving birth to children who are seriously impaired by birth defects. For instance, some cleft lips and palates are commonly attributed back to a mother’s use of the anti-nausea medication. Atrial septal and ventricular septal defects — both of which are heart defects — have also been linked to Zofran use during pregnancy.

Despite these risks, many obstetricians apparently remain unaware of the serious risk pregnant women and their unborn children are faced with when taking Zofran. This has led to Ohio families being unjustly burden with an unnecessary injury time and time again. We understand the struggle that parents of special needs children face, and we take great pride in the counsel and guidance that we provide to our clients seeking compensation for drug injuries.


What to do after a mesothelioma diagnosis
How to fund the war against opioid addiction in your community